New research has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use. The study looked at whether a type of diabetes medication, called GLP-1 ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

November is Diabetes awareness month. Diabetes (Diabetes mellitus) is a common endocrine disorder in all mammals, dogs and cats included. Diabetes is characterized by a dysfunction of insulin ...

World Diabetes Day is a global awareness campaign focusing on diabetes mellitus. The aim behind observing the day is to raise ...

Type 2 Diabetes, In Vivo Model, High-Voltage Electrotherapy, Glucose Tolerance Test (GTT), Hematological Analysis Kriman, V. (2024) Study of the Effect of High-Voltage Low-Frequency Electrotherapy on ...

Diabetes has plagued millions of people in the United States. Some of those people who are affected don’t know they have ...

Dr, Garner said, "Glucagon-like peptide-1 (GLP-1) receptor agonists represent a significant advancement in the treatment of ...